Bay Colony Advisory Group Inc d b a Bay Colony Advisors boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 21,581 shares of the company’s stock after purchasing an additional 700 shares during […]

Bay Colony Advisory Group Inc d b a Bay Colony Advisors grew its stake in shares of Oracle Co. (NYSE:ORCL – Free Report) by 0.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,726 shares of the enterprise software provider’s […]

Inscription Capital LLC decreased its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 2.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,015 shares of the company’s stock after selling 324 shares during the quarter. Inscription Capital LLC’s holdings in AstraZeneca […]

Bay Colony Advisory Group Inc d b a Bay Colony Advisors raised its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,345 shares of the healthcare product maker’s stock […]

Bay Colony Advisory Group Inc d b a Bay Colony Advisors cut its stake in shares of International Business Machines Co. (NYSE:IBM – Free Report) by 1.3% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 11,414 shares of the technology company’s stock after selling 156 shares during […]